ITRI vs NVDA

ITRI exhibits strong fundamental health with a Piotroski F-Score of 7/9 and a highly attractive valuation profile, trading significantly below its growth-based intrinsic value of $191.75. While the technical trend is bearish and insider sentiment is low, the company's profitability is robust with an ROE of 19.26% and a PEG ratio of 0.82, indicating the stock is undervalued relative to its earnings growth. The primary concern is a recent decline in revenue growth (-6.70%), though this is heavily offset by massive earnings growth (73.60%) and a consistent track record of earnings beats. Overall, the data suggests a value-driven entry point for a company with strong operational efficiency.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.